Algeta opens plant to make Xofigo; FDA passes Hermes plant; NASA eyes making drugs with 3-D printers;

> Norway's Algeta has opened a manufacturing facility at the Institute for Energy Technology (IFE) in Kjeller, Norway, to manufacture Xofigo, radium Ra 223 dichloride, the drug for castration-resistant prostate cancer which Bayer will commercialize. Release

> Hermes Pharma says it plant in Wolfratshausen, Germany, recently passed a routine FDA inspection. Release

> Indian pharmaceutical companies filed 417 Drug Master Files (DMFs) with the U.S. FDA in 2012, compared with 404 in the previous year. Report

> Polymer Group will build a plant in Nanhai, China to expand capacity of advanced chemical bond products for in the region. Report

And Finally... Will 3-D printing allow drugs to be manufactured in space for long trips to distant planets like Mars? More